Dataset for analysis of metabolic pathways and their reversibility associated with anti-proliferative effect of metformin in liver cancer cells
Open Access
- 28 May 2024
- journal article
- research article
- Published by Elsevier in Data in Brief
- Vol. 55, 110562
Abstract
No abstract availableKeywords
Funding Information
- India Department of Atomic Energy
- Department of Science and Technology (RJN-014)
This publication has 9 references indexed in Scilit:
- Identification of glucose-independent and reversible metabolic pathways associated with anti-proliferative effect of metformin in liver cancer cellsMetabolomics, 2024
- Metabolic reprogramming in cancer: Mechanisms and therapeuticsMedcomm, 2023
- Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?Biomolecules, 2021
- MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insightsNucleic Acids Research, 2021
- Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysisOncotarget, 2016
- Metabolic reprogramming: the emerging concept and associated therapeutic strategiesJournal of Experimental & Clinical Cancer Research, 2015
- Analysis of the ORFK1 hypervariable regions reveal distinct HHV-8 clustering in Kaposi’s sarcoma and non-Kaposi’s casesJournal of Experimental & Clinical Cancer Research, 2015
- Culture and Functional Characterization of Human Hepatoma HepG2 Cells2014
- Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-AnalysisThe Journal of Clinical Endocrinology & Metabolism, 2012